Ads are not configured at this scope yet
Full access
Psychopharmacology
Published Online: 2 December 2016

Industry Briefs

Vabren WattsAuthors Info & Affiliations
Volume 2, Number 20
https://doi.org/10.1176/appi.pn.2016.pp12a3
Track CitationsAdd to favorites
PDF/EPUB

Eli Lilly’s Alzheimer’s Therapy Fails in Phase 3 Clinical Trial

Eli Lilly and Co. announced last week that the experimental Alzheimer’s medication solanezumab did not meet the primary endpoint in a phase 3 clinical trial that included approximately 2,100 patients with mild dementia due to Alzheimer’s disease.
Trial results showed that solanezumab failed to significantly differ from placebo in slowing cognitive decline in patients treated for 18 months with the amyloid-targeting monoclonal antibody.
“Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to Alzheimer's disease,” the company stated in a release.

Zydus Issues Recall of Buprenorphine Hydrochloride Extended-Release Tablets

Zydus Pharmaceuticals USA Inc. has voluntarily recalled 20,537 bottles of 300 mg buprenorphine hydrochloride extended-release tablets (90-count bottles and 500-count bottles) that were made in India by the company’s subsidiary firm Cadila Healthcare, according to an FDA Enforcement Report.
The recall, which the FDA noted was due to “failed dissolution specifications,” has been designated a Class III recall—a classification indicating that the product is unlikely to cause any adverse health reaction but violates FDA labeling or manufacturing laws. ■

Information & Authors

Information

Published In

Go to Psychopharmacology
Volume 2 • Number 20 • December 2, 2016
Pages: 1

History

Published online: 2 December 2016
Published in print: December 2, 2016

Keywords

  1. Eli Lilly and Company
  2. Zydus Pharmaceuticals
  3. solanezumab
  4. Buprenorphine Hydrochloride Extended-Release

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.